These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity. Haghighat S; Siadat SD; Rezayat Sorkhabadi SM; Akhavan Sepahi A; Sadat SM; Yazdi MH; Mahdavi M Microb Pathog; 2017 Jul; 108():32-39. PubMed ID: 28457901 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice. Xu H; Hu C; Gong R; Chen Y; Ren N; Xiao G; Xie Q; Zhang M; Liu Q; Guo A; Chen H Clin Vaccine Immunol; 2011 Jun; 18(6):893-900. PubMed ID: 21508165 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of antibodies against proteins extracted from staphylococcal biofilm for the diagnosis of orthopedic prosthesis-related infections in an animal model and in humans. Wang X; Sadovskaya I; Leterme D; Watier D; Chokr A; Zhu Z; Jabbouri S Diagn Microbiol Infect Dis; 2013 Feb; 75(2):124-9. PubMed ID: 23182566 [TBL] [Abstract][Full Text] [Related]
6. Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection. Cole LE; Zhang J; Kesselly A; Anosova NG; Lam H; Kleanthous H; Yethon JA Infect Immun; 2016 Apr; 84(4):1143-1149. PubMed ID: 26857577 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcus epidermidis originating from titanium implants infects surrounding tissue and immune cells. Riool M; de Boer L; Jaspers V; van der Loos CM; van Wamel WJB; Wu G; Kwakman PHS; Zaat SAJ Acta Biomater; 2014 Dec; 10(12):5202-5212. PubMed ID: 25153780 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. Anderson AS; Scully IL; Timofeyeva Y; Murphy E; McNeil LK; Mininni T; Nuñez L; Carriere M; Singer C; Dilts DA; Jansen KU J Infect Dis; 2012 Jun; 205(11):1688-96. PubMed ID: 22474033 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of conjugated PIA-rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis. Mirzaei B; Mousavi SF; Babaei R; Bahonar S; Siadat SD; Shafiee Ardestani M; Shahrooei M; Van Eldere J J Med Microbiol; 2019 May; 68(5):791-802. PubMed ID: 30990402 [TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections. Adhikari RP; Thompson CD; Aman MJ; Lee JC Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice. Gong R; Hu C; Xu H; Guo A; Chen H; Zhang G; Shi L Clin Vaccine Immunol; 2010 Nov; 17(11):1746-52. PubMed ID: 20826613 [TBL] [Abstract][Full Text] [Related]
12. Montanide ISA 71 VG is Advantageous to Freund's Adjuvant in Immunization Against S. aureus Infection of Mice. Klimka A; Michels L; Glowalla E; Tosetti B; Krönke M; Krut O Scand J Immunol; 2015 May; 81(5):291-7. PubMed ID: 25689117 [TBL] [Abstract][Full Text] [Related]
13. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Sun D; Accavitti MA; Bryers JD Clin Diagn Lab Immunol; 2005 Jan; 12(1):93-100. PubMed ID: 15642991 [TBL] [Abstract][Full Text] [Related]
16. Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms. Ebert T; Smith S; Pancari G; Wu X; Zorman J; Clark D; Cook J; Burns C; Antonello JM; Cope L; Nagy E; Meinke A; McNeely T Hum Vaccin; 2011 Jun; 7(6):630-8. PubMed ID: 21508677 [TBL] [Abstract][Full Text] [Related]
17. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice. Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875 [TBL] [Abstract][Full Text] [Related]
19. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Van Mellaert L; Shahrooei M; Hofmans D; Eldere JV Expert Rev Vaccines; 2012 Mar; 11(3):319-34. PubMed ID: 22380824 [TBL] [Abstract][Full Text] [Related]
20. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate. Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]